Cargando…
Current status and prospects of GREM1 research in cancer (Review)
GREM1 is a secreted protein that antagonizes bone morphogenetic proteins (BMPs) and participates in critical biological processes, including embryonic development, organogenesis and tissue differentiation. Gremlin 1 (GREM1) is also an inhibitor of TGF-β and a ligand for vascular endothelial growth f...
Autores principales: | Zhu, Dantong, Zhao, Dong, Wang, Naixue, Cai, Fei, Jiang, Mingzhe, Zheng, Zhendong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442762/ https://www.ncbi.nlm.nih.gov/pubmed/37614374 http://dx.doi.org/10.3892/mco.2023.2665 |
Ejemplares similares
-
Current Situation and Prospect of Adoptive Cellular Immunotherapy for Malignancies
por: Zhao, Dong, et al.
Publicado: (2023) -
GREM1 is a potential biomarker for the progression and prognosis of bladder cancer
por: Jiang, Peng-cheng, et al.
Publicado: (2023) -
BMP signalling in human fetal ovary somatic cells is modulated in a gene-specific fashion by GREM1 and GREM2
por: Bayne, Rosemary A., et al.
Publicado: (2016) -
GREM
1 and POLE variants in hereditary colorectal cancer syndromes
por: Rohlin, Anna, et al.
Publicado: (2015) -
GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas
por: Kim, Hye Sung, et al.
Publicado: (2017)